ClariVest Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.75K | Hold |
96
| – | – | ﹤0.01% | 491 |
|
|
2024
Q2 | $2.75K | Buy |
96
+61
| +174% | +$1.75K | ﹤0.01% | 491 |
|
|
2024
Q1 | $1.02K | Hold |
35
| – | – | ﹤0.01% | 656 |
|
|
2023
Q4 | $1.18K | Hold |
35
| – | – | ﹤0.01% | 631 |
|
|
2023
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 689 |
|
|
2023
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 626 |
|
|
2023
Q1 | $1K | Sell |
35
-2
| -5% | -$57 | ﹤0.01% | 678 |
|
|
2022
Q4 | $1K | Hold |
37
| – | – | ﹤0.01% | 649 |
|
|
2022
Q3 | $2K | Hold |
37
| – | – | ﹤0.01% | 545 |
|
|
2022
Q2 | $2K | Sell |
37
-4,417
| -99% | -$239K | ﹤0.01% | 563 |
|
|
2022
Q1 | $340K | Sell |
4,454
-6
| -0.1% | -$458 | 0.01% | 430 |
|
|
2021
Q4 | $269K | Hold |
4,460
| – | – | 0.01% | 471 |
|
|
2021
Q3 | $249K | Hold |
4,460
| – | – | 0.01% | 474 |
|
|
2021
Q2 | $271K | Hold |
4,460
| – | – | 0.01% | 473 |
|
|
2021
Q1 | $312K | Hold |
4,460
| – | – | 0.01% | 460 |
|
|
2020
Q4 | $267K | Buy |
4,460
+4,400
| +7,333% | +$263K | 0.01% | 474 |
|
|
2020
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 572 |
|
|
2020
Q2 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 668 |
|